Avoid common mistakes on your manuscript.
Correction: World Journal of Urology (2022) 40:2063–2070 https://doi.org/10.1007/s00345-022-04071-7
In the original publication of the article, Group B and Group A in Row Group C was interchanged, and published incorrectly in Table 3. The correct Table 3 is given below:
The percent numbers between sildosen group and combination group in the text of Complications section were interchanged, and published incorrectly. The correct data is given below:
Complications
We found no statistically significant difference between the study groups with regard to complications, except for retrograde ejaculation. Retrograde ejaculation occurred among only 9.5% of patients receiving combination therapy, compared with 5.9% of patients receiving silodosin alone (Table 4). There was no incidence of acute retention or prostatitis during treatment period.
The original article has been corrected accordingly.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
AbdelRazek, M., Abolyosr, A., Mhammed, O. et al. Correction: Prospective comparison of tadalafil 5 mg alone, silodosin 8 mg alone, and the combination of both in treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. World J Urol 42, 434 (2024). https://doi.org/10.1007/s00345-024-05164-1
Published:
DOI: https://doi.org/10.1007/s00345-024-05164-1